Yet another clinical outcome flies in the face of our well-intentioned rad bio theories. Five-year quality of life outcomes for patients with prostate cancer enrolled in the CHHiP trial indicate there aren’t really any differences between fractionation arms, other than long-term sexual bother that was noted to be significantly worse with standard versus hypofractionation. | Staffurth, ASTRO 2018


Popular Posts